Cytokine-induced inhibition of insulin release from mouse pancreatic β-cells deficient in inducible nitric oxide synthase

Biochemical and Biophysical Research Communications

Volumn 281, Issue 2, 2001, Pages 396-403

  Andersson, Annika K ^a   Flodström, Malin ^a,b   Sandler, Stellan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

IFN ; IL 1 ; Inducible nitric oxide synthase; Insulin release; Islets of Langerhans; Nitric oxide

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CELL FUNCTION; CONTROLLED STUDY; ENZYME INDUCTION; GENE DELETION; GLUCOSE OXIDATION; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

RODENTIA;

EID: 0034808955     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4361     Document Type: Article

References (50)

1. Autoimmunity in insulin-dependent diabetes mellitus: Its detection and prevention
2. Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation
3. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: A 25-year review of deaths in patients under 20 years of age in the United Kingdom
4. Islet morphologic changes
5. Biochemical and molecular actions of interleukin-1 on pancreatic β-cells
6. The role of interleukin-1 in the pathogenesis of IDDM
7. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus
8. Inhibition of insulin secretion by interleukin-1 β and tumour necrosis factor-β via an L-arginine-dependent nitric oxide generating mechanism
9. Interleukin-1 β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase
10. Interleukin-1 β induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages
11. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation
12. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats
13. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4
14. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: Identification of
15. Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice
16. Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor
17. N omega-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats
18. Nitric oxide production in islets from nonobese diabetic mice: Aminoguanidine-sensitive and -resistant stages in the immunological diabetic process
19. Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozotocin injections in mice
20. Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozotocin-induced diabetes in mice
21. G-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat
22. S-methyl-L-thiocitrulline counteracts interleukin 1 β induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo
23. Effects of aminoguanidine on rat pancreatic islets in culture and on the pancreatic islet blood flow of anaesthetized rats
24. International union of pharmacology nomenclature in nitric oxide research
25. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis
26. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes
27. TNF-α and IFN-γ potentiate the deleterious effects of IL-1 β on mouse pancreatic islets mainly via generation of nitric oxide
28. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans
29. Role of the citrulline-nitric oxide cycle in the functional response of adult human and rodent pancreatic islets to cytokines
30. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells
31. Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine beta-cell damage
32. Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-)
33. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
34. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets
35. Determination of total serum insulin (IRI) in insulin-treated diabetic patients
36. Long-term exposure of isolated pancreatic islets to mannoheptulose: Evidence for insulin degradation in the beta cell
37. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
38. Viability tests of cryopreserved endocrine pancreatic cells
39. Protective effect of cyclosporin A and FK506 from nitric oxide- dependent apoptosis in activated macrophages
40. The early phase of glucose-stimulated insulin secretion requires nitric oxide
41. Morphological evidence for the existence of nitric oxide and carbon monoxide pathways in the rat islets of Langerhans: An immunocytochemical and confocal microscopical study
42. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 β indicate a perturbation in the mitochondrial function
43. Interleukin-1 β depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism
44. Interleukin-1 β induces an early decrease in insulin release, (pro)insulin biosynthesis and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis
45. Predominance of stimulatory effects of interleukin-1 β on isolated human pancreatic islets
46. Interleukin-1 β-induced stimulation of insulin release in mouse pancreatic islets is related to diacylglycerol production and protein kinase C activation
47. Interleukin-1 β induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets
48. Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release
49. Interleukin-1β-induced alteration in a β-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis
50. Cytokine- or chemically derived nitric oxide alters the expression of proteins detected by two-dimensional gel electrophoresis in neonatal rat islets of Langerhans